Plasma beta-2-microglobulin and fibronectin levels in beta-thalassaemia

Area of Science:

• Hematology
• Clinical Biochemistry

Background:

• Thalassaemia is a common inherited blood disorder.
• Beta 2-microglobulin (beta 2-MG) is a protein found on the surface of most nucleated cells.
• Reticuloendothelial system (RES) activity is often altered in chronic diseases.

Purpose of the Study:

• To investigate plasma beta 2-microglobulin (beta 2-MG) levels in children with thalassaemia.
• To explore the relationship between beta 2-MG levels, hypersplenism, and iron overload in this population.
• To assess fibronectin levels and their association with infection risk.

Main Methods:

• Plasma samples were collected from 118 children diagnosed with thalassaemia.
• Beta 2-microglobulin (beta 2-MG) levels were measured using a standard immunoassay.
• Fibronectin levels were also quantified.
• Data were analyzed to correlate beta 2-MG and fibronectin levels with clinical parameters like hypersplenism and iron overload.

Main Results:

• Children with thalassaemia exhibited higher mean plasma beta 2-MG levels compared to healthy controls.
• A significant association was found between elevated beta 2-MG and hypersplenism (3.14 +/- 0.6 mg/l).
• Plasma beta 2-MG levels correlated with markers of RES activity but showed no relationship with iron overload.
• Fibronectin levels were generally lower than in healthy adults, and low levels did not increase infection susceptibility.

Conclusions:

• Plasma beta 2-MG serves as a potential biomarker for reticuloendothelial system activity in thalassaemia.
• Beta 2-MG levels are linked to hypersplenism in thalassaemia patients.
• Fibronectin depletion in thalassaemia does not appear to compromise immune defense against infections.